Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology · Autoimmune Polyendocrine Syndrome Type 3

The Four Subtypes: Categorizing Your APS-3 Diagnosis

At a Glance

Autoimmune polyendocrine syndrome type 3 (APS-3) always involves autoimmune thyroid disease plus another autoimmune condition. Doctors classify it into four subtypes—3A, 3B, 3C, and 3D—based on the second condition to guide personalized screening and prevent future health issues.

While the name Autoimmune Polyendocrine Syndrome Type 3 (APS-3) describes the broad pattern of having thyroid disease plus another condition, doctors use four specific “subtypes” to better understand your unique health profile.

The “anchor” for every subtype is always Autoimmune Thyroid Disease (AITD), such as Hashimoto’s or Graves’ disease [1][2]. The specific subtype you are assigned depends entirely on which other organ system is being affected by your immune system.

The Four Subtypes of APS-3

Subtype Secondary Condition(s) Key Focus
APS-3A Type 1 Diabetes Mellitus [1][3] Metabolic Balance: Thyroid hormones can change how your body uses insulin, so these two conditions must be managed in sync [3].
APS-3B Pernicious Anemia or Autoimmune Gastritis [4][5] Nutrient Absorption: Your body may struggle to absorb Vitamin B12, requiring lifelong monitoring and occasional stomach screenings [6][7].
APS-3C Vitiligo, Alopecia, Myasthenia Gravis, or Celiac Disease [5][8] Organ-Specific Care: These conditions affect specific tissues like skin, hair, muscles, or the gut [5].
APS-3D Rheumatoid Arthritis, Sjögren’s, or Lupus (SLE) [9][10] Systemic Inflammation: These conditions cause widespread inflammation throughout the body rather than just one organ [9].

Understanding Your Risks and Presentation

The journey through APS-3 is different for everyone. It is very common for these conditions to appear years apart—sometimes the second condition doesn’t show up until decades after the first [11].

  • Subtype 3A Risks: Patients with 3A must be particularly vigilant about their blood sugar. Because thyroid levels can make you more or less sensitive to insulin, staying “balanced” requires close communication between you and your endocrinologist [3].
  • Subtype 3B Risks: Because autoimmune gastritis can change the lining of the stomach, patients in the 3B category are often advised to have regular endoscopic check-ups to monitor for early signs of stomach cell changes [6][12].
  • Subtype 3D Risks: While having a systemic disease like Lupus alongside thyroid disease sounds daunting, research suggests that the thyroid condition usually doesn’t make the Lupus itself “more aggressive” or harder to treat than it would be on its own [10].

Why Classification Matters

Categorizing your condition into these subtypes isn’t just about labels; it’s about prevention [13]. Once your doctor identifies your subtype, they know exactly which “neighboring” conditions to look for. For example, if you have 3B, your doctor knows to watch your B12 levels closely even before you feel the first signs of numbness or anemia [14]. This proactive approach is your best defense against the “lag time” between the start of an autoimmune process and the onset of symptoms [11].

Return to the Home Page.

Common questions in this guide

What defines Autoimmune Polyendocrine Syndrome Type 3?
APS-3 is defined by having an autoimmune thyroid disease, like Hashimoto's or Graves' disease, combined with at least one other autoimmune condition. The specific secondary condition determines which of the four subtypes you have.
What is the difference between APS-3A and APS-3B?
APS-3A involves thyroid disease paired with Type 1 Diabetes, requiring careful blood sugar management. APS-3B involves thyroid disease paired with autoimmune gastritis or pernicious anemia, which affects nutrient absorption and vitamin B12 levels.
Do the multiple conditions in APS-3 start at the same time?
Not necessarily. It is very common for these autoimmune conditions to appear years or even decades apart. This is why knowing your specific subtype is important for proactive monitoring and early screening.
What conditions are associated with APS-3D?
Subtype 3D involves systemic inflammatory conditions, such as Rheumatoid Arthritis, Sjögren’s syndrome, or Lupus, alongside autoimmune thyroid disease.
Will having thyroid disease make my Lupus or Rheumatoid Arthritis worse?
Research suggests that having a thyroid condition usually does not make systemic autoimmune diseases like Lupus more aggressive or harder to treat than they would be on their own.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current diagnoses, which specific subtype (3A, 3B, 3C, or 3D) do I have?
  2. 2.If I have APS-3B, how frequently should I undergo an endoscopy to monitor for gastric changes?
  3. 3.How does my thyroid health specifically impact the management of my secondary condition (e.g., insulin needs in 3A or joint inflammation in 3D)?
  4. 4.Are there specific 'potential' conditions associated with my subtype that we should be screening for even if I don't have symptoms yet?
  5. 5.What is the plan for multidisciplinary care between my endocrinologist and my other specialists?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.

    Betterle C, Furmaniak J, Sabbadin C, et al.

    Journal of endocrinological investigation 2023; (46(4)):643-665 doi:10.1007/s40618-022-01994-1.

    PMID: 36609775
  2. 2

    Autoimmune Polyglandular Syndrome Type 3 and Overlapping Autoimmune Endocrinopathies: A Case Report.

    Nagarajan DR, Mani Jacob D, Ottu Para NK

    Cureus 2025; (17(7)):e88574 doi:10.7759/cureus.88574.

    PMID: 40861566
  3. 3

    Superior Mesenteric Artery Syndrome Accompanied by Acute-onset Type 1 Diabetes Complicated with Graves' Disease.

    Sue-Nagumo M, Matsumoto S, Yamada E, et al.

    Internal medicine (Tokyo, Japan) 2022; (61(10)):1555-1560 doi:10.2169/internalmedicine.8364-21.

    PMID: 34645767
  4. 4

    Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study.

    Zulfiqar AA, Andres E

    Journal of medicine and life 2017; (10(4)):250-253.

    PMID: 29362601
  5. 5

    Severe Symptomatic Anemia as a Rare Initial Manifestation of Type 3 Polyglandular Autoimmune Syndrome: A Case Report.

    Goncalves H, De Oliveira Simões F, Sá R, et al.

    Cureus 2024; (16(12)):e75800 doi:10.7759/cureus.75800.

    PMID: 39816290
  6. 6

    Non-Invasive Markers for the Detection of Gastric Precancerous Conditions.

    Romańczyk M, Osmola M, Link A, et al.

    Cancers 2024; (16(12)) doi:10.3390/cancers16122254.

    PMID: 38927959
  7. 7

    Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency.

    Esposito G, Dottori L, Pivetta G, et al.

    Nutrients 2022; (14(8)) doi:10.3390/nu14081672.

    PMID: 35458234
  8. 8

    Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.

    Gobaru M, Ashida K, Yoshinobu S, et al.

    The American journal of case reports 2019; (20()):1709-1714 doi:10.12659/AJCR.918996.

    PMID: 31745069
  9. 9

    Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases.

    Jankowska K, Dudek P, Stasiek M, Suchta K

    Reumatologia 2023; (61(4)):225-238 doi:10.5114/reum/170266.

    PMID: 37745144
  10. 10

    A case-control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus.

    Piovani E, Gozzoli GI, Della Pina SEL, et al.

    Rheumatology (Oxford, England) 2025; (64(11)):5656-5664 doi:10.1093/rheumatology/keaf320.

    PMID: 40495344
  11. 11

    Epidemiological and clinical peculiarities of polyglandular syndrome type 3 in pediatric age.

    Valenzise M, Aversa T, Saccomanno A, et al.

    Italian journal of pediatrics 2017; (43(1)):69 doi:10.1186/s13052-017-0386-4.

    PMID: 28784159
  12. 12

    Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis.

    Yu Z, Wang A, Hu C, et al.

    Frontiers in medicine 2022; (9()):856125 doi:10.3389/fmed.2022.856125.

    PMID: 35783638
  13. 13

    Autoimmune Polyglandular Syndrome Type 3b: A Key to Diagnosing Autoimmune Gastritis and Asymptomatic Primary Biliary Cholangitis.

    Mabuchi S, Mabuchi H, Watari T

    European journal of case reports in internal medicine 2025; (12(6)):005376 doi:10.12890/2025_005376.

    PMID: 40502940
  14. 14

    [An adult case of Hashimoto's thyroiditis accompanying pernicious anemia and subacute combined degeneration].

    Shimozono K

    Rinsho shinkeigaku = Clinical neurology 2021; (61(7)):461-465 doi:10.5692/clinicalneurol.cn-001551.

    PMID: 34148933

This page provides educational information about APS-3 subtypes and related conditions. It is not a substitute for professional medical advice, and you should always consult your endocrinologist and medical team regarding your specific care plan.

Get notified when new evidence is published on Autoimmune polyendocrinopathy type 3.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.